Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in China / NCT01084967
Recruiting Observational

Genetics of Obesity in Chinese Youngs

NCT01084967 · tracked via the Priya Life Science China tracker
Sponsor
Shanghai Jiao Tong University School of Medicine
Phase
Observational
Started
2009-03
Last updated
2026-05-12

Condition(s) studied

ObesityMetabolic Syndrome

Study summary

The purpose of this study is to explore the pathogenesis and genetic susceptibility of obese subjects,providing a convincing argument for further treatment of obesity and metabolic syndrome.

Eligibility

Sex
ALL
Min age
14 Years
Max age
30 Years
Healthy volunteers
Accepted
Inclusion Criteria: * body mass index (BMI)≥ 30kg/m2 * predominantly east China to minimize population stratification * willing and able to provide informed consent Exclusion Criteria: * pregnancy/lactation * Cushing syndrome * Hypothyroidism * obesity caused by pituitary and hypothalamic lesions * drug related obesity * history of major psychiatric illness

Trial sites (1)

FacilityCityRegionStatus
Shanghai Jiao Tong University School of Medicine Shanghai Shanghai Municipality Recruiting

More Shanghai Jiao Tong University School of Medicine trials in China

Doxycycline for Helicobacter Pylori Rescue Treatment Recruiting
FM Technique in Orthodontic Clear Aligner Therapy: A Single-Arm Clinical Study Recruiting
Electronic Blood Pressure Monitor for Atrial Fibrillation Detection Starting soon
Treatment of Chidamide and Venetoclax for Retinoic Acid and Arsenic Resistant Acute Promyelocytic Leukemia Recruiting
Active Surveillance and Safety/Efficacy Evaluation of Innovative Devices for Structural Heart Disease Intervention Recruiting

Other trials for the same condition

Probiotic for Weight Management in Overweight and Obese Adults Starting soon
Influence of HDM1005 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin Starting soon
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes Active, not recruiting
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity Recruiting
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT01084967 on ClinicalTrials.gov ↗ ← All trials in China